Verita Healthcare named Integrative Healthcare Group and Health Tech Innovator of the Year 2026

JAKARTA, Indonesia - Verita Healthcare are proud to be recognized as Integrative Healthcare Group of the Year in Asia-Pacific 2026 and Health Tech Innovator of the Year in Asia-Pacific 2026 at the Global Health Asia-Pacific Awards.

The prestigious event was held at the Grand Hyatt in the Indonesian capital of Jakarta with Chief Executive Officer Julian Andriesz and Chief Medical Officer Dr Abdulla El-Hossami being present to collect the awards. The dual recognition reflects work across the Group's specialist brands - Verita Life, Verita Neuro, Verita Health and Regenetec - and the clinicians, scientists, partners and patients behind it.

This marks the 5th Global Health and Travel Award that Verita Healthcare has been awarded since 2016, showcasing our consistency in excellence and continued commitment to pushing the boundaries of innovation in the integrative healthcare space.

Highlight achievements from this year’s awards include the publication of Verita Neuro's Phase II Epidural Electrical Stimulation trial in the Journal of Central Nervous System Disease in collaboration with the University of São Paulo, the regional launch of the FDA-cleared ReWalk® 7 Personal Exoskeleton through an exclusive partnership with NASDAQ-listed Lifeward, and the introduction of VIBA™ - the Verita Index of Biological Age - developed in collaboration with the University of Vienna.

A full write-up has been featured in the award edition of Global Health Asia-Pacific magazine.